PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
24-Feb-2020 Almirall and Paratek enter into a License Agreement for Seysara® in China Almirall
24-Feb-2020 Positive long-term data in retinal clinical trial ReNeuron Group plc
24-Feb-2020 FDA approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the first and only intravenous preventive treatment for migraine H. Lundbeck A/S
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
24-Feb-2020 Genmab Board of Directors Chairman to Step Down Genmab
24-Feb-2020 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2019 Results Presentation and Webcast Nordic Nanovector
24-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin Co., Ltd
24-Feb-2020 Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis Altair Medical
22-Feb-2020 Save your dates for Cardiac Surgery 2020 Congress in Edinburgh, Scotland. Allied Academies
21-Feb-2020 Kyowa Kirin Announces Approval of CRYSVITA® (burosumab) in Switzerland for the Treatment of Adults and Children with X-Linked Hypophosphatemia (XLH) Kyowa Kirin
21-Feb-2020 Exclusive interview with Pharma Microbiology Boston Conference Chair Lynne Ensor, speaks about Coronavirus SMi Group
21-Feb-2020 Exclusive Interview with Martin Everett, CSO, Antabio, ahead of the Superbugs & Superdrugs Conference SMi Group
21-Feb-2020 Thousands of patients to benefit from new way to pick up prescriptions at Boots UK Boots UK
21-Feb-2020 First Patient Dosed with Transgene’s Oncolytic Virus TG6002, Administered by Intrahepatic Artery Infusion in Colorectal Cancer with Liver Metastases Transgene
21-Feb-2020 Statement regarding Major Holdings NMC HEALTH PLC
20-Feb-2020 Blood Cancer Charity, Anthony Nolan, Selects IGEL Endpoints to Boost Workplace Collaboration and Support Windows 10 Migration RealWire
20-Feb-2020 Vifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron portfolio Vifor Pharma Group
20-Feb-2020 Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline Polyphor
20-Feb-2020 Montis Biosciences launched with €8,4 million seed financing and a novel approach to immuno-oncology Montis Biosciences
20-Feb-2020 Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis Galderma